World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: SLCTR
Last refreshed on: 27 April 2013
Main ID:  SLCTR/2007/007
Date of registration: 14/06/2007
Primary sponsor: IAEA research grant SRL 11958
Public title: Folic acid status in Sri Lanka in pregnant and lactating women
Scientific title: Folate status in two groups of pregnant and non-pregnant/ non-lactating women in Sri Lanka
Date of first enrolment: 30/4/2007
Target sample size: 200 pregnant women (100 per group)
Recruitment status: Completed
URL:  http://www.slctr.lk/trial_details.asp?reg_id={C83E11B7-2121-4CB6-84AF-7A2D2A23C48A}
Study type:  Interventional
Study design:  Pregnant women (n=200) who are at present participating in an ongoing study will be followed up for a period of six months post partum  
Countries of recruitment
Sri Lanka
Contacts
Name: Prof. Chandrani Liyanage 
Address:  Nuclear Medicine Unit, Faculty of Medicine, University of Ruhuna, Galle
Telephone: +94 91 2234801
Email: nmu_galle@yahoo.com
Affiliation:  Prof in Community Medicine and Head Nuclear Medicine
Name: Prof. Chandrani Liyanage 
Address:  Nuclear Medicine Unit, Faculty of Medicine, University of Ruhuna, Galle
Telephone: +94 91 2234801
Email: nmu_galle@yahoo.com
Affiliation:  Prof in Community Medicine and Head Nuclear Medicine
Key inclusion & exclusion criteria
Inclusion criteria: Healthy pregnant women who come for the booking visit and ante-natal clinic
Exclusion criteria: Severely anaemic and iron deficient pregnant women

Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Micronutrient status of lactating mothers
Intervention(s)
The pregnant women who are enrolled will be divided into two groups based on their follow-up center; i.e. pregnant women selected from MCH clinics and pregnant women from TH-Mahamodara. Then folate supplementation will be continued for a period of six months post partum to the MCH group only. Their folate status at the end of supplementation will be compared with that of non supplemented lactating women of TH Mahamodara group.
Primary Outcome(s)
Improvement in folate status of women during early lactation
Secondary Outcome(s)
•Improvement in folate status of lactating mothers and infants

•Improving awareness on general nutritional status of the community
Secondary ID(s)
IAEA-SRL-11958, research grant sponsor -international atomic energy agency
Source(s) of Monetary Support
International Atomic Energy Agency (IAEA)
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history